|
Ammonia N 13 Injection
» Ammonia N 13 Injection is a sterile solution of 13NH3 in Sodium Chloride Injection, suitable for intravenous administration, in which a portion of the molecules are labeled with radioactive 13N (see Radiopharmaceuticals for Positron Emission TomographyCompounding
Specific activity:
no carrier added.
Packaging and storage
Preserve in single-dose or multiple-dose containers that are adequately shielded.
Labeling
Label it to include the following, in addition to the information specified for Labeling under Injections
Identification
A:
Radionuclidic identityIts half-life, determined using a suitable detector system (see Radioactivity
B:
Radiochemical identityThe retention time of the major peak in the chromatogram of the Test solution corresponds to that in the chromatogram of the Standard solution, as obtained in the Radiochemical purity test.
Bacterial endotoxins
pH
Radiochemical purity
Mobile phase
Add 0.25 mL of concentrated nitric acid to 1000 mL of a mixture of water and methanol (7:3), filter, and degas.
Standard solution
Dissolve an accurately weighed quantity of USP Ammonium Chloride RS in water, and dilute quantitatively, and stepwise if necessary, with water to obtain a solution having a known concentration of about 0.1 mg per mL.
Test solution
Use the Injection.
Chromatographic system (see Chromatography
Procedure
Prepare a mixture of the Standard solution and the Test solution (1:1), and inject about 20 µL of the mixture into the chromatograph, record the chromatograms, and measure the peak areas. The areas of both the main radioactive and nonradioactive peaks are equal. [noteThe volume of Injection may be adjusted to obtain suitable detection system sensitivity.] The radioactivity of the major peak is not less than 95% of the total radioactivity measured. The retention time of the Test solution corresponds to the retention time of the Standard solution.
Radionuclidic purity
Using a suitable gamma-ray spectrometer (see Selection of a Counting Assembly under Radioactivity
Chemical purity
This article may be synthesized by different methods and processes and, therefore, contains different impurities. The presence of unlabeled ingredients, reagents, and by-products specific to the process must be controlled, and their potential for physiological or pharmacological effects must be considered.
aluminum
(to be determined if Devarda's alloy is used to reduce 13N nitrate/nitrite)
Aluminum standard solution
Transfer 35.17 mg of aluminum potassium sulfate dodecahydrate, accurately weighed, to a 1000-mL volumetric flask, and dilute with water to volume to obtain a solution having a known concentration of 2 µg of aluminum per mL.
Procedure
Pipet 10 mL of Aluminum standard solution into each of two 50-mL volumetric flasks. To each flask add 3 drops of methyl orange TS and 2 drops of 6 N ammonium hydroxide, then add 0.5 N hydrochloric acid, dropwise, until the solution turns red. To one flask add 25 mL of sodium thioglycolate TS, and to the other flask add 1 mL of edetate disodium TS. To each flask add 5 mL of eriochrome cyanine TS and 5 mL of acetate buffer TS, and add water to volume. Immediately determine the absorbance of the solution containing sodium thioglycolate TS at the wavelength of maximum absorbance at about 535 nm, with a suitable spectrophotometer, using the solution containing the edetate disodium TS as a blank. Repeat the procedure using two 1.0-mL aliquots of Injection. Calculate the quantity, in µg per mL, of aluminum in the Injection taken by the formula:
20(TU / TS)
in which TU and TS are the absorbances of the solutions from the Injection and the Aluminum standard solution, respectively. The concentration of aluminum ion in the Injection is not greater than 10 µg per mL.
Other requirements
It meets the requirements under Injections
Assay for radioactivity
Using a suitable calibrated system as directed under Radioactivity
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 3095
Pharmacopeial Forum: Volume No. 29(3) Page 641
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|